Xybion completes the acquisition of all operating assets of Amadeus Solutions

NewsGuard 100/100 Score

Xybion Corporation announced today that through the creation of a wholly owned Quebec Corporation, Services Informatiques Xybion, it has completed the acquisition of all operating assets of Quebec City based Amadeus Solutions, a leader in the development of enterprise governance, risk, compliance and quality management software solutions, from DECIMAL, a corporate performance management organization headquartered in Montreal.

Amadeus has been partnering with organizations in life sciences, manufacturing, finance and government sectors to manage risk, quality and compliance. The Amadeus's eQCM(R) web-based software platform enables organizations to comply with requirements stemming from FDA, ISO and other regulatory standards (like GxP, FDA 21 CFR Part 11, ISO 9001, ISO14001), financial reporting and governance regulations (Sarbanes-Oxley and Canada Bill 198), and other industry standards and risk-based regulations. Designed for maximum flexibility and easy adaptation to an organizations unique Governance, Compliance & Risk management (GRC) processes, eQCM(R) is coupled with powerful business intelligence capabilities, enterprise content management , and related technologies that help organizations achieve sustained compliance and improve process performance.

"Amadeus further strengthens our holistic strategic approach to delivering enterprise solutions to our life science and medical research partners. Combining Xybion's more than 30 years of experience in providing software solutions to global pharmaceutical, CRO and life science companies through it's Pristima and Pristima VM platforms, Amadeus's GRC platform will offer our clients a single partner for their enterprise needs in the regulated environment." said Dr. Pradip K. Banerjee, Chairman and CEO of Xybion Corporation. "By leveraging the strengths of our different divisions and staff, and working with our customers in thirteen countries, we are able to provide solutions that no other company can match today", said Michael Tucker, a veteran of the life science and process management software industries who has been appointed as Vice President and General Manager of Amadeus.

"Initially, we were searching for a partner to help to expand our penetration of the US and European life sciences market with the Amadeus solutions," remarked Stéphane Gaouette, president of DECIMAL, "During our time of reviewing each other's capabilities and core competencies, it became evident that Xybion should take a leading role in moving the Amadeus products and services forward." While Amadeus will be a wholly owned division of Xybion Corporation, DECIMAL will retain a position on the board of directors of Amadeus business to continue to provide guidance and insight for product and market growth. DECIMAL will also be a partner with Xybion, retaining exclusive rights in Quebec for distribution of Amadeus' Internal Controls Management (ICM) product.

All of the employees of Amadeus have been retained by Services Informatiques Xybion. The Quebec City office will function as Xybion's Center of Excellence for the GRC business.

Source: XYBION

Source: AMADEUS

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Columbia researchers secure $38.95 million ARPA-H contract to build a living knee replacement